Simbrinza Ophthalmic Drops contain a combination of brimonidine and brinzolamide. Brimonidine and brinzolamide reduce the amount of fluid in the eye, which decreases pressure inside the eye. Simbrinza is used to treat open-angle glaucoma or ocular hypertension (high pressure inside the eye).
This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists.This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing.